Zoledronate Generic 3mg/15ml Concentrate Vial from Canada
Concentrated zoledronic acid salt solution 3mg in 15ml vial requiring dilution for tumor-induced hypercalcemia treatment, supplied in single-dose glass packaging. Classified under HTS 3004.90.92.75 for its specific zoledronic acid salt content in measured therapeutic doses.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit import drug alert notice 72 hours prior via FDA PREDICT system; ensure vial labeling includes 'dilute before use' and osmolarity warnings; test for leachables from glass primary packaging